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Abstract
During hematopoiesis, lineage- and stage-specific transcription factors work in concert with
chromatin modifiers to direct the differentiation of all blood cells. Here, we explored the role of
KRAB-containing zinc finger proteins (KRAB-ZFPs) and their cofactor KAP1 in this process.
Hematopoietic-restricted deletion of Kap1 in the mouse resulted in severe hypoproliferative
anemia. Kap1-deleted erythroblasts failed to induce mitophagy-associated genes and retained
mitochondria. This was due to persistent expression of microRNAs targeting mitophagy
transcripts, itself secondary to a lack of repression by stage-specific KRAB-ZFPs. The KRAB/
KAP1-miRNA regulatory cascade is evolutionary conserved, as it also controls mitophagy during
human erythropoiesis. Thus, a multilayered transcription regulatory system is present, where
protein- and RNA-based repressors are super-imposed in combinatorial fashion to govern the
timely triggering of an important differentiation event.
Through the process of erythropoiesis, about one hundred billion new red cells are generated
every day in the human adult bone marrow. This process is initiated by the differentiation of
hematopoietic stem cells (HSC) into the earliest erythroid progenitor, which was identified
ex vivo as a slowly growing burst-forming unit-erythroid (BFU-E). This erythroid
progenitor morphs into the rapidly dividing CFU-E (colony-forming unit-erythroid), the
proliferation of which is stimulated by the hypoxia-induced hormone erythropoietin. Further
differentiation occurs through a highly sophisticated program orchestrated by lineage- and
stage-specific combinations of protein- and RNA-based transcription regulators (1–3). It
culminates in the elimination of intracellular organelles including mitochondria and the
nucleus to yield the fully mature erythrocyte, containing on the order of 250 million
molecules of hemoglobin as almost sole cargo. Much is still to be learned about the
molecular mechanisms of these events, not only to understand the cause of red cell
disorders, but also to aid the in vitro manufacturing of the large supplies of oxygen-carrying
cells for transfusion.
Higher vertebrate genomes encode hundreds of KRAB-ZFPs that can bind DNA in a
sequence-specific fashion through a C-terminal array of C2H2 zinc fingers and recruit the
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corepressor KAP1 via their N-terminal KRAB domain (4–7). KAP1, also known as TRIM28
(tripartite motif protein 28), TIF1β (transcription intermediary factor 1 beta) or KRIP-1
(KRAB-interacting protein 1), acts as a scaffold for a multimolecular complex that silences
transcription through the formation of heterochromatin (8–11). The KRAB/KAP1 system
probably evolved initially to minimize retroelement-induced genome perturbations (12–14),
but recent data indicate that it also regulates multiple aspects of mammalian physiology (15–
24). The present study was undertaken to explore its role in hematopoiesis.
The hemato-specific knockout of Kap1 in the mouse, whereby the hematopoietic system of
otherwise wild type animals is reconstituted from Kap1-deleted hematopoietic stem cells
and progenitors (fig. S1), resulted in a series of hematological abnormalities (table S1).
Mutant mice displayed fatal hyporegenerative anemia, characterized by the accumulation of
transferrin receptor/CD71+ glycophorin-A-associated/Ter119− early erythroblasts and an
almost complete absence of mature CD71−Ter119+ cells in the bone marrow (Fig. 1A).
Electron microscopy and Mitotracker staining revealed that KO erythroblasts contain more
mitochondria than their wild type counterparts (Fig. 1B), correlating with decreased
expression of mitophagy genes such as Nix/Bnip3L, Ulk1, GABARAPl2, Sh3glb1, Atg12,
Becn1 and Bcl2l1 (Fig. 2A). Since the KRAB/KAP1 pathway is mostly known to induce
transcriptional repression (10, 11), it seemed likely that this effect was indirect. An
examination of the miRNA expression profile of control and Kap1 KO CD71+Ter119+ cells
revealed that, among 455 miRNAs tested, 5 were downregulated and 11 upregulated more
than two-fold in KO cells (data are presented in the Gene Expression Omnibus dataset
GSE44061). A recently described in silico approach (25, 26) suggested that six of these
upregulated miRNAs had mitophagy-associated deregulated transcripts as their targets,
notably miR-351, predicted to act on Bnip3L (Fig. 2A). Consistent with this hypothesis,
levels of miR-351 abruptly dropped in CD71+Ter119+ cells, compared to their
CD71+Ter119− precursors, mirroring Bnip3L induction (Fig. 2B). Furthermore,
transduction of mouse erythroleukemia (MEL) cells with a GFP-expressing lentiviral vector
harboring, 3′ of GFP, the Bnip3L 3′UTR sequence predicted to be targeted by miR-351
resulted in miR-351-dependent downregulation of the reporter (Fig. 2C). Finally, similar to
their KAP1-depleted counterparts, miR-351-overexpressing MEL cells were blocked in
differentiation and accumulated mitochondria, and this phenotype was reversed by
expression of a Bnip3L transcript devoid of this 3′UTR sequence (fig. S2).
MiR-503 and miR-322*, which are located next to miR-351 on chromosome X, were also
upregulated (2.46 and 2.17 fold, respectively) in Kap1 KO erythroblasts. Consistent with a
role for KRAB/KAP1 in regulating this miRNA gene cluster, chromatin
immunoprecipitation coupled to DNA sequencing (ChIPSeq) detected a strong KAP1 peak
less than 4kb away (Fig. 3A). Because KAP1 is not a DNA binding protein, we postulated
that it might be tethered to this and other relevant loci by stage-specific KRAB-ZFPs. Nine
KRAB-ZFP genes were identified, which had human orthologs and were expressed
exclusively in CD71+Ter119− and/or CD71+Ter119+ erythroblasts, but not in other
hematopoietic cells. Six of these genes could be efficiently knocked down in MEL cells by
lentivector-mediated RNA interference, and two of them, ZFP689 and ZFP13, emerged as
potential Bnip3L regulators (fig. S3). Interestingly, ZFP689 is expressed in CD71+Ter119+
erythroblasts, whereas ZFP13 is expressed only in their CD71−Ter119+ counterparts (Fig.
3B). Both could repress reporter expression in MEL cells transduced with a lentiviral vector
harboring the miR-351-close KAP1-binding site upstream of a human phosphoglycerate
kinase promoter murine secreted alkaline phosphatase (mSEAP) cassette (Fig. 3C). We then
validated these two candidates in vivo by transplanting CD45.2 hematopoietic stem cells
(lineage−, Sca1+ and cKit+, or LSK) transduced with lentiviral vectors producing GFP and
shRNAs against Zfp689, Zfp13, or Kap1 as a control, into irradiated CD45.1 mice, allowing
the dual discrimination of donor vs. recipient and transduced vs. untransduced cells.
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Analyses of the red cell compartment in bone marrow harvested eight weeks after the graft
revealed that knockdown of either Zfp689 or Zfp13 led to a decrease in CD71+Ter119−
cells as pronounced as that observed with the Kap1 knockdown (Fig. 3D). Furthermore,
RNA analyses of sorted transduced CD71+Ter119+ cells demonstrated that ZFP689−,
ZFP13− and KAP1-depleted cells all exhibited an upregulation of miR-351 (Fig. 3E) and a
marked downregulation of Bnip3L (Fig. 3F).
In a last series of experiments, we asked whether this erythropoiesis-regulating system has
its equivalent in humans. We first found that Kap1 knockdown impaired the differentiation
of human erythroleukemia (HEL) cells and increased their mitochondrial content (Fig.
4ABC), blocking several mitophagy effectors including Nix/Bnip3L (Fig. 4D). We further
verified that KAP1-depleted HEL cells had increased levels of hsa-miR-125a-5p (Fig. 4D),
which has the same seed as murine miR-351, and that overexpressing this miRNA triggered
a downregulation of Nix and a rise in the mitochondrial content of these cells (Fig. 4E).
Finally, when we knocked down Kap1 in human cord blood CD34+ cells, it resulted in
decreasing their ability to undergo cytokine-induced ex vivo erythroid differentiation, which
correlated with reduced Nix expression and elevated mitochondrial content (Fig. 4F), a
phenotype that could be reproduced by hsa-miR-125a overexpression (Fig. 4G).
These results unveil a multilayered transcription regulatory system, where protein- and
RNA-based repressors are super-imposed in combinatorial fashion to govern the timely
triggering of a necessary step of erythropoiesis. miR-351 and several other microRNAs with
predicted targets in the mitophagy pathway were upregulated in Kap1-deleted murine
erythroblasts (Fig. 2). This apparent redundancy, or rather addition of parallel effects aimed
at a same physiological process, is commonly observed with RNA interference (27). Our
discovery that it can be further modulated by KRAB-ZFP-mediated repression, and that the
latter can itself be multifactorial, adds a remarkable level of modularity to this type of
regulation. In human erythroblasts, although KAP1 represses the Nix-targeting hsa-
miR-125a-5p, downregulation of several other miRNAs, including hsa-miR-24, -221, -222,
and -223, was previously found important for erythroid differentiation, which conversely
requires the upregulation of hsa-miR-144/451 cluster (2, 3). Whether stage-specific KRAB-
ZFPs are involved in controlling some of these other miRNAs remains to be determined.
Even though KAP1 likely influences erythropoiesis by more than just allowing mitophagy, it
is interesting to note that Znf205 and Znf689, the respective human orthologs of murine
Zfp13 and Zfp689, are expressed in HEL cells and induced upon erythroid differentiation of
CD34+ cells (fig. S4). Therefore, polymorphism or mutations in any genetic component of
the pathway unveiled here, whether Znf205, Znf689, the genomic binding sites of their
products, hsa-miR-125a-5p and other KAP1-regulated miRNA genes, or the sequences
targeted by these RNA regulators, could underlie red cell-related pathologies such as
anemia, polycythemia, or erythroleukemia.
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Blocked erythrocyte maturation and accumulation of mitochondria in Kap1-deleted
erythroblasts. (A) FACS analysis of CD71 and Ter119 in bone marrow from control (Ctrl)
and Kap1 KO mice 7 weeks after pIC injection. Percentage of each population from the total
bone marrow is indicated. (B) Electron microscopy (left, stars indicate mitochondria;
middle, average number of mitochondria visualized per cell; n = 10, *p < 0.05) and
Mitotracker staining (right, n = 4, *p < 0.05). Decreased nuclear density was frequent in
Kap1 KO cells, perhaps reflecting altered chromatin condensation.
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A KAP1-miRNA cascade controls red cell mitophagy. (A) Top, mitophagy-related
transcripts in erythroblasts from control (Ctrl) and Kap1 KO mice (n = 4, *p < 0.05, **p <
0.01, ***p < 0.001). Bottom, indicated miRNAs expression in same samples; predicted
miRNA-target pairs are indicated by X. (B) miR351 and Bnip3L expression in
megakaryocyte/erythroid progenitors (MEP: Lin–Sca1–CD117+ CD34–CD16.32–, in which
expression was set at 1) and indicated erythroblast subsets. (C) MiR-351 targets the Bnip3L
3′UTR. Ctrl, for which the normalized value was set at 1, was a combination of MEL cells
not overexpressing miR-351 and transduced with a GFP-expressing lentiviral vector with the
Bnip3L 3′UTR, and cells overexpressing miR-351 but transduced with the same vector
without this sequence (n = 3, *p < 0.05).
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Erythroblast-specific KRAB-ZFPs control the miR-351/Bnip3L/mitophagy axis. A Screen
shots from the UCSC Genome Browser, with results of a KAP1 ChIPSeq analysis
performed on CD71+Ter119+ bone marrow cells. (B) Zfp689 and Zfp13 are induced during
erythroid differentiation. (C) ZFP689 and ZFP13 repress a lentiviral vector carrying a
miR-351-close KAP1-binding site in transduced MEL cells (Ctrl is a combination of ZFP-
overexpressing cells transduced with a vector without the KAP1-binding site and cells
LacZ-overexpressing cells transduced with a vector carrying the KAP1-binding site; n = 3,
*p < 0.05). (D) CD45.2+ LSK cells were transduced with GFP-expressing, empty or
scramble (Ctrl), Kap1-, Zfp689- or Zfp13-directed shRNA lentiviral vectors, engrafted into
irradiated CD45.1+ mice, and erythroid differentiation was evaluated by FACS 8 wks later.
(E and F) The CD71+Ter119+, CD45.2+, eGFP+ population was then sorted and analyzed
by RT-QPCR for miR351 (E) and Bnip3L (F) expression (n = 6, *p < 0.05).
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KAP1-regulated RNA interference controls human red cell mitophagy. (A to C) HEL
transduced with scramble or Kap1-specific shRNA-expressing lentiviral vectors and induced
or not to differentiate were evaluated for Kap1 mRNA expression (A), and by benzidine (B)
(n = 3, counting 100 cells for each condition) or Mitotracker (C) (n = 3) staining (*p < 0.05).
(D) hsa-miR-125a-5p (miR125a) and Nix expression measured respectively by NanoString
nCounter direct RNA quantification and RNA sequencing in HEL cells transduced with
empty or Kap1 knockdown vectors. (E) Nix expression in Ctrl (setting normalized value at
1) or hsa-miR-125a-5p-overexpressing HEL cells, measuring their mitochondrial content by
Mitotracker staining (n = 4, *p < 0.05). (F) Decreased erythroid differentiation of Kap1
knockdown human cord blood CD34+ cells, assessed by CD235a surface expression at
seven (D7) and eleven (D11) days. At D7, sorted CD235a+eGFP+ cells were analyzed by
RT-QPCR for Nix and hsa-miR125a expression, and for mitochondrial content by
Mitotracker staining (n = 3, *p < 0.05). (G) Percentage of CD235a-expressing cells 7 days
after inducing the differentiation of CD34+ cells transduced with empty or unrelated-
miRNA- (Ctrl) or hsa-miR-125a-5p-overexpressing lentiviral vectors (n = 3, *p < 0.05).
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